How much does ELUNATE (Fruquintinib Capsules) Cost& price without insurance in China?
ELUNATE® is the commercial brand name of Fruquintinib Capsules, an orally active VEGFR tyrosine kinase inhibitor developed by Hutchison MediPharma and licensed to Eli Lilly. It selectively inhibits vascular endothelial growth factor receptors (VEGFR1, 2, 3), blocking tumor angiogenesis and suppressing tumor growth.
Main Indications
Treatment of metastatic colorectal cancer (mCRC) in adult patients who have received prior fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy, and anti-VEGF or anti-EGFR therapy (if RAS wild-type).
Common Side Effects
Common mild adverse reactions: Hypertension, proteinuria, hand-foot skin reaction, diarrhea, and fatigue.
Laboratory abnormalities: Elevated transaminases, hypoalbuminemia, and thrombocytopenia.
Severe but uncommon risks: Severe hypertension, arterial thromboembolic events, gastrointestinal perforation, and hemorrhage.
Approval Status in China
ELUNATE® (Fruquintinib Capsules, 1mg) was officially approved for marketing in China in 2018. It is currently a prescription anti-tumor drug included in China’s Category B medical insurance.
Buy ELUNATE (Fruquintinib Capsules) online from China and save up to 80% on costs . no insurance needed . compare prices from a certified HongKong pharmacy .with fast shipping. Contact us now on WhatsApp to get the latest prices.
